RDX-013
- Generic Name
- RDX-013
A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 109
- Registration Number
- NCT04780841
- Locations
- 🇺🇸
Horizon Research Group LLC, Coral Gables, Florida, United States
🇺🇸Panax Clinical Research LLC, Miami Lakes, Florida, United States
🇺🇸NW Louisiana Nephrology Assoc, Shreveport, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath